{"id":22853,"date":"2025-04-11T11:57:10","date_gmt":"2025-04-11T09:57:10","guid":{"rendered":"https:\/\/medisynt.com\/?page_id=22584"},"modified":"2025-05-09T15:04:25","modified_gmt":"2025-05-09T13:04:25","slug":"radionuclide","status":"publish","type":"page","link":"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/","title":{"rendered":"Radionuclide"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row equal_height=&#8221;yes&#8221; css=&#8221;.vc_custom_1590861654857{padding-top: 80px !important;padding-bottom: 10px !important;}&#8221;][vc_column offset=&#8221;vc_col-lg-offset-2 vc_col-lg-8 vc_col-md-offset-1 vc_col-md-10 vc_col-sm-offset-0&#8243; css=&#8221;.vc_custom_1590861393199{padding-bottom: 10px !important;}&#8221;]<div id=\"ultimate-heading-157669dd11b2152fd\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-157669dd11b2152fd uvc-417 accent-border-color accent-title-color\" data-hspacer=\"line_only\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-157669dd11b2152fd h2'  data-responsive-json-new='{\"font-size\":\"desktop:40px;mobile_landscape:30px;\",\"line-height\":\"desktop:50px;mobile_landscape:40px;\"}' ><h2 style=\"--font-weight:theme;margin-bottom:0px;\">Radionuclide<\/h2><\/div><div class=\"uvc-heading-spacer line_only\" style=\"margin-bottom:5px;height:3px;\"><span class=\"uvc-headings-line\" style=\"border-style:solid;border-bottom-width:3px;border-color:;width:150px;\"><\/span><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-157669dd11b2152fd .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:20px;mobile_landscape:18px;\",\"line-height\":\"desktop:26px;mobile_landscape:24px;\"}'  style=\"font-weight:normal;\">Targeted molecular radiotherapy<\/div><\/div>[vc_column_text css=&#8221;.vc_custom_1746795809281{padding-top: 10px !important;}&#8221;]<\/p>\n<p style=\"text-align: center;\">medisynt offers three highly effective radionuclides\u2014Terbium-161 (Tb-161), Lutetium-177 (Lu-177), and Actinium-225 (Ac-225)\u2014which are used in targeted molecular radiotherapy for the treatment of various cancers.<\/p>\n<p style=\"text-align: center;\">These radionuclides are distinguished by their ability to precisely destroy tumor cells while largely sparing surrounding healthy tissue. In addition, medisynt plans to expand its portfolio in the near future with further innovative radionuclides to meet the growing demands of personalized cancer therapy.<\/p>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row bg_type=&#8221;bg_color&#8221; bg_override=&#8221;ex-full&#8221; css=&#8221;.vc_custom_1727166348087{padding-top: 50px !important;padding-bottom: 60px !important;}&#8221; bg_color_value=&#8221;#edeff1&#8243;][vc_column css=&#8221;.vc_custom_1690461626805{padding-top: 0px !important;}&#8221;]<style type=\"text\/css\" data-type=\"the7_shortcodes-inline-css\">.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.bottom-overlap-layout-list .post-entry-content {\n  margin-top: -100px;\n  width: 75%;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.bottom-overlap-layout-list:not(.mode-list) .no-img .post-entry-content {\n  margin-top: 0;\n  width: 100%;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.bottom-overlap-layout-list.mode-list .no-img .post-entry-content {\n  margin-top: 0;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .filter-bg-decoration .filter-categories a.act {\n  color: #fff;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d:not(.mode-masonry) article:first-of-type,\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d:not(.mode-masonry) article.visible.first {\n  margin-top: 0;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.dividers-on:not(.mode-masonry) article {\n  margin-top: 0;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.dividers-on:not(.mode-masonry) article:first-of-type,\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.dividers-on:not(.mode-masonry) article.visible.first {\n  margin-top: 0;\n  padding-top: 0;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.hover-scale article:after {\n  background: rgba(0,122,164,0.88);\n  -webkit-box-shadow: none;\n  box-shadow: none;\n  background: -webkit-linear-gradient();\n  background: linear-gradient();\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.gradient-overlay-layout-list article {\n  border-radius: 0px;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-thumbnail-wrap {\n  padding: 0px 0px 0px 0px;\n  border-radius: 0px;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-thumbnail-wrap *,\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-thumbnail-rollover:after {\n  border-radius: 0px;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.enable-bg-rollover .post-thumbnail-rollover:after {\n  background: rgba(0,122,164,0.88);\n  -webkit-box-shadow: none;\n  box-shadow: none;\n  background: -webkit-linear-gradient();\n  background: linear-gradient();\n}\n.bottom-overlap-layout-list.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container {\n  height: calc(100% - 100px);\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a {\n  width: 44px;\n  height: 44px;\n  line-height: 44px;\n  border-radius: 100px;\n  margin: 10px 5px 10px;\n}\n.content-rollover-layout-list:not(.content-align-center).portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a,\n.gradient-overlay-layout-list:not(.content-align-center).portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a {\n  margin: 10px 10px 10px 0;\n}\n.dt-icon-border-on.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a:before {\n  border-width: 0px;\n  border-style: solid;\n}\n.dt-icon-hover-border-on.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a:after {\n  border-width: 0px;\n  border-style: solid;\n}\n.dt-icon-bg-on.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a:before {\n  background: #ffffff;\n  -webkit-box-shadow: none;\n  box-shadow: none;\n}\n.dt-icon-hover-bg-on.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a:after {\n  background: rgba(255,255,255,0.83);\n  -webkit-box-shadow: none;\n  box-shadow: none;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a > span,\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a > span:before {\n  font-size: 16px;\n  line-height: 44px;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a:not(:hover) > span {\n  color: #007aa4;\n}\n.dt-icon-hover-off.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a > span,\n.dt-icon-hover-off.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a:hover > span {\n  color: #007aa4;\n}\n.dt-icon-hover-on.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-links-container a:hover > span {\n  color: #007aa4;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .entry-title,\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.owl-carousel .entry-title {\n  margin-bottom: 5px;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .entry-title a,\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.owl-carousel .entry-title a {\n  color: #007aa4;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .entry-meta {\n  margin-bottom: 15px;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .entry-meta * {\n  color: #ffffff;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .portfolio-categories {\n  margin-bottom: 15px;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .entry-meta > a:after,\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .entry-meta > span:after {\n  background: #ffffff;\n  -webkit-box-shadow: none;\n  box-shadow: none;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .entry-excerpt {\n  margin-bottom: 5px;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .entry-excerpt * {\n  color: #060e18;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d:not(.centered-layout-list) .post-entry-content {\n  padding: 25px 30px 30px 30px;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d:not(.centered-layout-list):not(\n      .content-bg-on\n    ):not(.mode-list)\n    .no-img\n    .post-entry-content {\n  padding: 0;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.content-bg-on:not(.classic-layout-list):not(\n      .centered-layout-list\n    ):not(.gradient-overlay-layout-list)\n    .post-entry-content {\n  background: #edeff1;\n  -webkit-box-shadow: none;\n  box-shadow: none;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.gradient-overlay-layout-list .post-entry-content {\n  border-radius: 0px;\n}\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-details.details-type-link,\n.portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-details.details-type-link * {\n  color: #007aa4;\n}\n@media screen and (max-width: ) {\n  .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d article {\n    -webkit-flex-flow: column nowrap;\n    -moz-flex-flow: column nowrap;\n    -ms-flex-flow: column nowrap;\n    flex-flow: column nowrap;\n    margin-top: 20px;\n  }\n  .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.dividers-on article {\n    border: none;\n  }\n  .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.content-bg-on.centered-layout-list article {\n    padding: 0;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-thumbnail-wrap,\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-entry-content {\n    width: 100%;\n    margin: 0;\n    top: 0;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-thumbnail-wrap {\n    padding: 0;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-entry-content:after {\n    display: none;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .project-even .post-thumbnail-wrap,\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.centered-layout-list .post-thumbnail-wrap {\n    -webkit-order: 0;\n    -moz-order: 0;\n    -ms-flex-order: 0;\n    order: 0;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.centered-layout-list .post-entry-title-content {\n    -webkit-order: 1;\n    -moz-order: 1;\n    -ms-flex-order: 1;\n    order: 1;\n    width: 100%;\n    padding: 20px 20px 0;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d.centered-layout-list .post-entry-content {\n    -webkit-order: 2;\n    -moz-order: 2;\n    -ms-flex-order: 2;\n    order: 2;\n    padding-top: 0;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-entry-content {\n    padding: 20px;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .entry-title {\n    margin: 3px 0 5px;\n    font-size: 20px;\n    line-height: 26px;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .entry-meta {\n    margin: 5px 0 5px;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .entry-excerpt {\n    margin: 15px 0 0;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-details {\n    margin: 5px 0 10px;\n  }\n  #page .portfolio-shortcode.portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d .post-details.details-type-link {\n    margin-bottom: 2px;\n  }\n}<\/style><div class=\"portfolio-shortcode portfolio-masonry-shortcode-id-298106084f3e2c19d3500a40882ae14d mode-masonry bottom-overlap-layout-list content-bg-on jquery-filter content-align-center dt-icon-bg-on dt-icon-border-on dt-icon-hover-on dt-icon-hover-bg-on meta-info-off enable-bg-rollover resize-by-browser-width  loading-effect-none description-under-image \" data-padding=\"15px\" data-cur-page=\"1\" data-post-limit=\"-1\" data-pagination-mode=\"none\" data-desktop-columns-num=\"3\" data-v-tablet-columns-num=\"2\" data-h-tablet-columns-num=\"3\" data-phone-columns-num=\"1\" data-width=\"0px\" data-columns=\"0\"><div class=\"iso-container\" ><div class=\"visible wf-cell iso-item\" data-post-id=\"22664\" data-date=\"2024-08-10T16:57:18+02:00\" data-name=\"Lu-177 Chlorid (NCA)\"><article class=\"post visible post-22664 dt_portfolio type-dt_portfolio status-publish post-password-required hentry dt_portfolio_category-nuclear-medicine dt_portfolio_category-radionuclide-nuclear-medicine dt_portfolio_category-108 dt_portfolio_category-149\" data-name=\"Protected: Lu-177 Chlorid (NCA)\" data-date=\"2024-08-10T16:57:18+02:00\">\n\n<div class=\"post-thumbnail-wrap forward-post \">\n\t<div class=\"post-thumbnail\">\n\n\t\t<a href=\"https:\/\/medisynt.com\/en\/radiation-oncology-and-radiology\/lu-177-chlorid-nca\/\" class=\"post-thumbnail-rollover layzr-bg\" target=\"\"  aria-label=\"Post image\"><img fetchpriority=\"high\" decoding=\"async\" class=\"iso-lazy-load preload-me iso-lazy-load aspect\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20768%20576&#39;%2F%3E\" data-src=\"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2025\/04\/Lu-177-Chlorid-NCA-Uebersicht-768x576.jpg\" data-srcset=\"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2025\/04\/Lu-177-Chlorid-NCA-Uebersicht-768x576.jpg 768w, https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2025\/04\/Lu-177-Chlorid-NCA-Uebersicht.jpg 900w\" loading=\"eager\" style=\"--ratio: 768 \/ 576\" sizes=\"(max-width: 768px) 100vw, 768px\" alt=\"Lu-177 Chlorid (NCA)\" title=\"Lu-177 Chlorid (NCA)\" width=\"768\" height=\"576\"  \/><\/a><div class=\"project-links-container\"><a href=\"https:\/\/medisynt.com\/en\/radiation-oncology-and-radiology\/lu-177-chlorid-nca\/\" target=\"\" class=\"project-details\" aria-label=\"Details link\"><span class=\"icon-portfolio-p205\"><\/span><\/a><\/div>\n\t<\/div>\n<\/div>\n\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/medisynt.com\/en\/radiation-oncology-and-radiology\/lu-177-chlorid-nca\/\" target=\"\" title=\"Protected: Lu-177 Chlorid (NCA)\" rel=\"bookmark\">Protected: Lu-177 Chlorid (NCA)<\/a>\n\t<\/h3>\n\n\t\n\t<div class=\"entry-excerpt\"><form action=\"https:\/\/medisynt.com\/en\/wp-login.php?action=postpass\" class=\"post-password-form\" method=\"post\"><input type=\"hidden\" name=\"redirect_to\" value=\"https:\/\/medisynt.com\/en\/radiation-oncology-and-radiology\/lu-177-chlorid-nca\/\" \/>\n\t<p>This content is password-protected. To view it, please enter the password below.<\/p>\n\t<p><label for=\"pwbox-22664\">Password: <input name=\"post_password\" id=\"pwbox-22664\" type=\"password\" spellcheck=\"false\" required size=\"20\" \/><\/label> <input type=\"submit\" name=\"Submit\" value=\"Enter\" \/><\/p><\/form>\n\t<\/div>\n\t\n<\/div><\/article><\/div><div class=\"visible wf-cell iso-item\" data-post-id=\"22045\" data-date=\"2024-08-09T11:05:22+02:00\" data-name=\"Ac-225 Chloride (NCA)\"><article class=\"post visible post-22045 dt_portfolio type-dt_portfolio status-publish has-post-thumbnail hentry dt_portfolio_category-nuclear-medicine dt_portfolio_category-radionuclide-nuclear-medicine dt_portfolio_category-108 dt_portfolio_category-149\" data-name=\"Ac-225 Chloride (NCA)\" data-date=\"2024-08-09T11:05:22+02:00\">\n\n<div class=\"post-thumbnail-wrap rollover-active \">\n\t<div class=\"post-thumbnail\">\n\n\t\t<a href=\"https:\/\/medisynt.com\/en\/radiation-oncology-and-radiology\/ac-225-chloride-nca\/\" class=\"post-thumbnail-rollover layzr-bg\" target=\"\"  aria-label=\"Post image\"><img decoding=\"async\" class=\"iso-lazy-load preload-me iso-lazy-load aspect\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20700%20525&#39;%2F%3E\" data-src=\"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2024\/08\/Ac-225-Chloride-Uebersicht.jpg\" data-srcset=\"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2024\/08\/Ac-225-Chloride-Uebersicht.jpg 700w\" loading=\"eager\" style=\"--ratio: 700 \/ 525\" sizes=\"(max-width: 700px) 100vw, 700px\" alt=\"Ac-225 Chloride (NCA)\" title=\"Ac-225 Chloride (NCA)\" width=\"700\" height=\"525\"  \/><\/a><div class=\"project-links-container\"><a href=\"https:\/\/medisynt.com\/en\/radiation-oncology-and-radiology\/ac-225-chloride-nca\/\" target=\"\" class=\"project-details\" aria-label=\"Details link\"><span class=\"icon-portfolio-p205\"><\/span><\/a><\/div>\n\t<\/div>\n<\/div>\n\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/medisynt.com\/en\/radiation-oncology-and-radiology\/ac-225-chloride-nca\/\" target=\"\" title=\"Ac-225 Chloride (NCA)\" rel=\"bookmark\">Ac-225 Chloride (NCA)<\/a>\n\t<\/h3>\n\n\t\n\t<div class=\"entry-excerpt\"><p>Highly effective radioisotope used in targeted alpha therapies.<\/p>\n<\/div>\n\t\n<\/div><\/article><\/div><div class=\"visible wf-cell iso-item\" data-post-id=\"22035\" data-date=\"2024-08-08T10:51:30+02:00\" data-name=\"Tb-161 Chlorid (NCA)\"><article class=\"post visible post-22035 dt_portfolio type-dt_portfolio status-publish has-post-thumbnail hentry dt_portfolio_category-nuclear-medicine dt_portfolio_category-radionuclide-nuclear-medicine dt_portfolio_category-108 dt_portfolio_category-149\" data-name=\"Tb-161 Chlorid (NCA)\" data-date=\"2024-08-08T10:51:30+02:00\">\n\n<div class=\"post-thumbnail-wrap rollover-active \">\n\t<div class=\"post-thumbnail\">\n\n\t\t<a href=\"https:\/\/medisynt.com\/en\/radiation-oncology-and-radiology\/terbium-161\/\" class=\"post-thumbnail-rollover layzr-bg\" target=\"\"  aria-label=\"Post image\"><img decoding=\"async\" class=\"iso-lazy-load preload-me iso-lazy-load aspect\" src=\"data:image\/svg+xml,%3Csvg%20xmlns%3D&#39;http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg&#39;%20viewBox%3D&#39;0%200%20600%20450&#39;%2F%3E\" data-src=\"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2024\/08\/Terbium-161-Uebersicht.jpg\" data-srcset=\"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2024\/08\/Terbium-161-Uebersicht.jpg 600w\" loading=\"eager\" style=\"--ratio: 600 \/ 450\" sizes=\"(max-width: 600px) 100vw, 600px\" alt=\"\" title=\"Terbium-161-Uebersicht\" width=\"600\" height=\"450\"  \/><\/a><div class=\"project-links-container\"><a href=\"https:\/\/medisynt.com\/en\/radiation-oncology-and-radiology\/terbium-161\/\" target=\"\" class=\"project-details\" aria-label=\"Details link\"><span class=\"icon-portfolio-p205\"><\/span><\/a><\/div>\n\t<\/div>\n<\/div>\n\n\n<div class=\"post-entry-content\">\n\n\t<h3 class=\"entry-title\">\n\t\t<a href=\"https:\/\/medisynt.com\/en\/radiation-oncology-and-radiology\/terbium-161\/\" target=\"\" title=\"Tb-161 Chlorid (NCA)\" rel=\"bookmark\">Tb-161 Chlorid (NCA)<\/a>\n\t<\/h3>\n\n\t\n\t<div class=\"entry-excerpt\"><p>produced at the highest radiochemical grade under non-GMP conditions, available in 0.05M HCl Solution.<\/p>\n<\/div>\n\t\n<\/div><\/article><\/div><\/div><!-- iso-container|iso-grid --><\/div>[\/vc_column][\/vc_row][vc_row equal_height=&#8221;yes&#8221; bg_type=&#8221;bg_color&#8221; bg_override=&#8221;ex-full&#8221; css=&#8221;.vc_custom_1592388442222{margin-top: 5px !important;padding-top: 0px !important;padding-bottom: 0px !important;}&#8221; bg_color_value=&#8221;#edeff1&#8243;][vc_column css=&#8221;.vc_custom_1591118513478{padding-bottom: 20px !important;background-position: center !important;background-repeat: no-repeat !important;background-size: cover !important;}&#8221; offset=&#8221;vc_col-lg-12 vc_col-md-12&#8243;][vc_row_inner equal_height=&#8221;yes&#8221; content_placement=&#8221;middle&#8221;][vc_column_inner css=&#8221;.vc_custom_1591118388188{padding-top: 0px !important;}&#8221;]<div id=\"ultimate-heading-30969dd11b218068\" class=\"uvc-heading ult-adjust-bottom-margin ultimate-heading-30969dd11b218068 uvc-52 accent-border-color accent-title-color\" data-hspacer=\"line_only\"  data-halign=\"center\" style=\"text-align:center\"><div class=\"uvc-main-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-30969dd11b218068 h2'  data-responsive-json-new='{\"font-size\":\"desktop:28px;mobile_landscape:24px;\",\"line-height\":\"desktop:34px;mobile_landscape:30px;\"}' ><h2 style=\"--font-weight:theme;margin-top:30px;margin-bottom:15px;\">Contact us<\/h2><\/div><div class=\"uvc-heading-spacer line_only\" style=\"margin-bottom:25px;height:3px;\"><span class=\"uvc-headings-line\" style=\"border-style:solid;border-bottom-width:3px;border-color:;width:150px;\"><\/span><\/div><div class=\"uvc-sub-heading ult-responsive\"  data-ultimate-target='.uvc-heading.ultimate-heading-30969dd11b218068 .uvc-sub-heading '  data-responsive-json-new='{\"font-size\":\"desktop:22px;mobile_landscape:18px;\",\"line-height\":\"desktop:28px;mobile_landscape:24px;\"}'  style=\"font-weight:normal;\">Questions? Feedback? Call us or send us a message!<\/div><\/div>\n\t\t\t<div class=\"ult_dual_button  vc_custom_1726673219955 ult-adjust-bottom-margin to-center  \"  data-response=\"on\" id=\"ult_btn_1678685847\">\n\n\t\t\t<div id=\"dualbtn-3374\" class=\"ulitmate_dual_buttons ult-dual-btn ult_main_dualbtn \" data-bcolor=\"#333333\"data-bhcolor=\"\">\n\n\t\t\t<div class=\"ult_dualbutton-wrapper btn-inline place-template bt1 \"><a href=\"tel:+41625622380\" title=\"You can reach us by telephone\"  class=\"ult_ivan_button round-square with-icon icon-after with-text place-template ult_dual1\" style=\";margin-right:px;;background-color:#007aa4 !important;; border-color:#333333;border-style:;border-width:0px;border-radius:px;width:400px;;\">\n\t\t\t<span class=\"ult-dual-btn-1 Style 1\" style=\"\"  data-bgcolor=\"#007aa4\" data-bghovercolor=\"#afb6bd\" data-icon_color=\"#ffffff\" data-icon_hover_color=\"#ffffff\" data-textcolor=\"#ffffff\" data-texthovercolor=\"#ffffff\" data-iconbgcolor=\"transperent\" data-iconbghovercolor=\"transperent\" data-iconborder=\"transperent\" data-iconhoverborder=\"transperent\" >\n\n\t\t\t<span class=\"text-btn ult-dual-button-title title_left ult-responsive \"  data-ultimate-target='#dualbtn-3374 .ult-dual-button-title'  data-responsive-json-new='{\"font-size\":\"desktop:16px;\",\"line-height\":\"desktop:24px;\"}'   style=\"font-weight:normal;color:#ffffff;\">You can reach us by telephone<\/span>\n\t\t\t<span class=\"icon-simple icon-right1 ult_btn1span \"  style=\"; \">\n<span class=\"aio-icon btn1icon none \"  style=\"color:#ffffff;font-size:24px;display:inline-block;\">\n\t<i class=\"icomoon-the7-font-the7-phone-06\" ><\/i>\n<\/span><\/span\n\t\t\t<\/span>\n\t\t\t<\/a><span class=\"middle-text\" style=\"line-height: 1.8em;color:#060e18;background-color:#ffffff;border-width:0px;\">\n\t\t\t<span class=\"middle-inner\"  >or<\/span>\n\t\t\t<\/span>\n\n\t\t\t<\/div>\n\n\t\t\t<div class=\"ult_dualbutton-wrapper btn-inline place-template btn2 \"><a href=\"\/en\/contact\" title=\"Contact us\"  class=\"ult_ivan_button round-square with-icon icon-after with-text place-template ult_dual2\"  style=\";background-color:#afb6bd !important;;margin-left:px;;border-color:#333333;border-style:;border-width:0px;border-radius:px;width:400px;\">\n\t\t\t<span class=\"ult-dual-btn-2 Style 1\"  data-bgcolor=\"#afb6bd\" data-bghovercolor=\"#007aa4\" data-icon_color=\"#ffffff\" data-icon_hover_color=\"#ffffff\" data-textcolor=\"#ffffff\" data-texthovercolor=\"#ffffff\" data-iconbgcolor=\"transperent\" data-iconbghovercolor=\"transperent\" data-iconborder=\"transperent\" data-iconhoverborder=\"transperent\" >\n\t\t\t<span class=\"text-btn ult-dual-button-title\" style=\"font-weight:normal;color:#ffffff;\">Contact us<\/span>\n\n\t\t\t<span class=\"icon-simple icon-right2 ult_btn1span \"  style=\"; \">\n<span class=\"aio-icon btn1icon none \"  style=\"color:#ffffff;font-size:24px;display:inline-block;\">\n\t<i class=\"fas fa-mail-bulk\" ><\/i>\n<\/span><\/span>\n\t\t\t<\/span>\n\t\t\t<\/a><\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>[\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row equal_height=&#8221;yes&#8221; css=&#8221;.vc_custom_1590861654857{padding-top: 80px !important;padding-bottom: 10px !important;}&#8221;][vc_column offset=&#8221;vc_col-lg-offset-2 vc_col-lg-8 vc_col-md-offset-1 vc_col-md-10 vc_col-sm-offset-0&#8243; css=&#8221;.vc_custom_1590861393199{padding-bottom: 10px !important;}&#8221;][vc_column_text css=&#8221;.vc_custom_1746795809281{padding-top: 10px !important;}&#8221;] medisynt offers three highly effective radionuclides\u2014Terbium-161 (Tb-161), Lutetium-177 (Lu-177), and Actinium-225 (Ac-225)\u2014which are used in targeted molecular radiotherapy for the treatment of various cancers. These radionuclides are distinguished by their ability to precisely destroy tumor cells while&hellip;<\/p>\n","protected":false},"author":1,"featured_media":22084,"parent":20522,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-microsite.php","meta":{"footnotes":""},"class_list":["post-22853","page","type-page","status-publish","has-post-thumbnail","hentry","description-off"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Radionuclide&#187; Targeted molecular radiotherapy&#187; medisynt<\/title>\n<meta name=\"description\" content=\"Radionuclide \u27a4 Targeted molecular radiotherapy \u279f Tb-161 Chlorid (NCA) \u27a4 Ac-225 Chloride (NCA) \u279f Lu-177 Chlorid (NCA)\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Radionuclide\" \/>\n<meta property=\"og:description\" content=\"Radionuclide \u27a4 Targeted molecular radiotherapy \u279f Tb-161 Chlorid (NCA) \u27a4 Ac-225 Chloride (NCA) \u279f Lu-177 Chlorid (NCA)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/\" \/>\n<meta property=\"og:site_name\" content=\"medisynt\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=100063312725136#\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-09T13:04:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2024\/08\/Ac-225-Chloride-Menue.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"300\" \/>\n\t<meta property=\"og:image:height\" content=\"225\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/nuclear-medicine\\\/radionuclide\\\/\",\"url\":\"https:\\\/\\\/medisynt.com\\\/en\\\/nuclear-medicine\\\/radionuclide\\\/\",\"name\":\"Radionuclide&#187; Targeted molecular radiotherapy&#187; medisynt\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/nuclear-medicine\\\/radionuclide\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/nuclear-medicine\\\/radionuclide\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/medisynt.com\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/08\\\/Ac-225-Chloride-Menue.jpg\",\"datePublished\":\"2025-04-11T09:57:10+00:00\",\"dateModified\":\"2025-05-09T13:04:25+00:00\",\"description\":\"Radionuclide \u27a4 Targeted molecular radiotherapy \u279f Tb-161 Chlorid (NCA) \u27a4 Ac-225 Chloride (NCA) \u279f Lu-177 Chlorid (NCA)\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/nuclear-medicine\\\/radionuclide\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/medisynt.com\\\/en\\\/nuclear-medicine\\\/radionuclide\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/nuclear-medicine\\\/radionuclide\\\/#primaryimage\",\"url\":\"https:\\\/\\\/medisynt.com\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/08\\\/Ac-225-Chloride-Menue.jpg\",\"contentUrl\":\"https:\\\/\\\/medisynt.com\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2024\\\/08\\\/Ac-225-Chloride-Menue.jpg\",\"width\":300,\"height\":225,\"caption\":\"Ac-225 Chloride (NCA) Radionuclide organ-specific preparations\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/nuclear-medicine\\\/radionuclide\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/medisynt.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nuclear Medicine\",\"item\":\"https:\\\/\\\/medisynt.com\\\/en\\\/nuclear-medicine\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Radionuclide\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/medisynt.com\\\/en\\\/\",\"name\":\"medisynt\",\"description\":\"medisynt EN\",\"publisher\":{\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/medisynt.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/#organization\",\"name\":\"medisynt AG\",\"url\":\"https:\\\/\\\/medisynt.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/medisynt.com\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2020\\\/06\\\/medisynt-152px_152px.png\",\"contentUrl\":\"https:\\\/\\\/medisynt.com\\\/en\\\/wp-content\\\/uploads\\\/sites\\\/2\\\/2020\\\/06\\\/medisynt-152px_152px.png\",\"width\":152,\"height\":152,\"caption\":\"medisynt AG\"},\"image\":{\"@id\":\"https:\\\/\\\/medisynt.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=100063312725136#\",\"https:\\\/\\\/www.instagram.com\\\/medisyntgroup\\\/\"],\"email\":\"office@medisynt.com\",\"telephone\":\"+41 62 562 23 80\",\"legalName\":\"medisynt AG\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Radionuclide&#187; Targeted molecular radiotherapy&#187; medisynt","description":"Radionuclide \u27a4 Targeted molecular radiotherapy \u279f Tb-161 Chlorid (NCA) \u27a4 Ac-225 Chloride (NCA) \u279f Lu-177 Chlorid (NCA)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/","og_locale":"en_GB","og_type":"article","og_title":"Radionuclide","og_description":"Radionuclide \u27a4 Targeted molecular radiotherapy \u279f Tb-161 Chlorid (NCA) \u27a4 Ac-225 Chloride (NCA) \u279f Lu-177 Chlorid (NCA)","og_url":"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/","og_site_name":"medisynt","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=100063312725136#","article_modified_time":"2025-05-09T13:04:25+00:00","og_image":[{"width":300,"height":225,"url":"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2024\/08\/Ac-225-Chloride-Menue.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/","url":"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/","name":"Radionuclide&#187; Targeted molecular radiotherapy&#187; medisynt","isPartOf":{"@id":"https:\/\/medisynt.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/#primaryimage"},"image":{"@id":"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/#primaryimage"},"thumbnailUrl":"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2024\/08\/Ac-225-Chloride-Menue.jpg","datePublished":"2025-04-11T09:57:10+00:00","dateModified":"2025-05-09T13:04:25+00:00","description":"Radionuclide \u27a4 Targeted molecular radiotherapy \u279f Tb-161 Chlorid (NCA) \u27a4 Ac-225 Chloride (NCA) \u279f Lu-177 Chlorid (NCA)","breadcrumb":{"@id":"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/#primaryimage","url":"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2024\/08\/Ac-225-Chloride-Menue.jpg","contentUrl":"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2024\/08\/Ac-225-Chloride-Menue.jpg","width":300,"height":225,"caption":"Ac-225 Chloride (NCA) Radionuclide organ-specific preparations"},{"@type":"BreadcrumbList","@id":"https:\/\/medisynt.com\/en\/nuclear-medicine\/radionuclide\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medisynt.com\/en\/"},{"@type":"ListItem","position":2,"name":"Nuclear Medicine","item":"https:\/\/medisynt.com\/en\/nuclear-medicine\/"},{"@type":"ListItem","position":3,"name":"Radionuclide"}]},{"@type":"WebSite","@id":"https:\/\/medisynt.com\/en\/#website","url":"https:\/\/medisynt.com\/en\/","name":"medisynt","description":"medisynt EN","publisher":{"@id":"https:\/\/medisynt.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medisynt.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/medisynt.com\/en\/#organization","name":"medisynt AG","url":"https:\/\/medisynt.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/medisynt.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2020\/06\/medisynt-152px_152px.png","contentUrl":"https:\/\/medisynt.com\/en\/wp-content\/uploads\/sites\/2\/2020\/06\/medisynt-152px_152px.png","width":152,"height":152,"caption":"medisynt AG"},"image":{"@id":"https:\/\/medisynt.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=100063312725136#","https:\/\/www.instagram.com\/medisyntgroup\/"],"email":"office@medisynt.com","telephone":"+41 62 562 23 80","legalName":"medisynt AG"}]}},"_links":{"self":[{"href":"https:\/\/medisynt.com\/en\/wp-json\/wp\/v2\/pages\/22853","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medisynt.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/medisynt.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/medisynt.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/medisynt.com\/en\/wp-json\/wp\/v2\/comments?post=22853"}],"version-history":[{"count":4,"href":"https:\/\/medisynt.com\/en\/wp-json\/wp\/v2\/pages\/22853\/revisions"}],"predecessor-version":[{"id":22901,"href":"https:\/\/medisynt.com\/en\/wp-json\/wp\/v2\/pages\/22853\/revisions\/22901"}],"up":[{"embeddable":true,"href":"https:\/\/medisynt.com\/en\/wp-json\/wp\/v2\/pages\/20522"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medisynt.com\/en\/wp-json\/wp\/v2\/media\/22084"}],"wp:attachment":[{"href":"https:\/\/medisynt.com\/en\/wp-json\/wp\/v2\/media?parent=22853"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}